Insider Trading & Ownership of Sessa Capital (Master), L.P.

Location: New York, NY
Summary: The estimated value of insider holdings of Sessa Capital (Master), L.P. is at least $3,847,299 dollars as of 01 Oct 2025. Sessa Capital (Master), L.P. is the Director of SAB Biotherapeutics, Inc. and owns shares of SAB Biotherapeutics, Inc. (SABS) stock worth about $3.85M.
Signature: /s/ John Petry, for Sessa Capital (Master), L.P., By: Sessa Capital GP, LLC, its general partner, By: John Petry, as manager
All Insider Reports: All Insider Reports

Notify me when Sessa Capital (Master), L.P. files a new Insider Trading report.

Ownership of Sessa Capital (Master), L.P.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SABS, SABSW	SAB Biotherapeutics, Inc.	Director	$3,847,299			29 Sep 2025
PRVB	Provention Bio, Inc.	10%+ Owner				27 Apr 2023

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.